299 related articles for article (PubMed ID: 32571540)
1. Spironolactone in Dermatology: Uses in Acne, Hidradenitis Suppurativa, Female Pattern Baldness, and Hirsutism.
Vargas-Mora P; Morgado-Carrasco D
Actas Dermosifiliogr (Engl Ed); 2020 Oct; 111(8):639-649. PubMed ID: 32571540
[TBL] [Abstract][Full Text] [Related]
2. Spironolactone in dermatology.
Aguilar Medina DA; Cazarín J; Magaña M
Dermatol Ther; 2022 May; 35(5):e15321. PubMed ID: 35038224
[TBL] [Abstract][Full Text] [Related]
3. Spironolactone in dermatology: uses in acne and beyond.
Searle TN; Al-Niaimi F; Ali FR
Clin Exp Dermatol; 2020 Dec; 45(8):986-993. PubMed ID: 32844462
[TBL] [Abstract][Full Text] [Related]
4. Use of spironolactone in dermatology.
Rathnayake D; Sinclair R
Skinmed; 2010; 8(6):328-32; quiz 333. PubMed ID: 21413648
[TBL] [Abstract][Full Text] [Related]
5. Dermatological indications for the use of isotretinoin beyond acne.
Forbat E; Ali FR; Al-Niaimi F
J Dermatolog Treat; 2018 Nov; 29(7):698-705. PubMed ID: 29480033
[TBL] [Abstract][Full Text] [Related]
6. Oral spironolactone therapy for female patients with acne, hirsutism or androgenic alopecia.
Burke BM; Cunliffe WJ
Br J Dermatol; 1985 Jan; 112(1):124-5. PubMed ID: 3155956
[No Abstract] [Full Text] [Related]
7. Zinc in dermatology.
Searle T; Ali FR; Al-Niaimi F
J Dermatolog Treat; 2022 Aug; 33(5):2455-2458. PubMed ID: 35437093
[TBL] [Abstract][Full Text] [Related]
8. Polycystic ovary syndrome: a review for dermatologists: Part II. Treatment.
Buzney E; Sheu J; Buzney C; Reynolds RV
J Am Acad Dermatol; 2014 Nov; 71(5):859.e1-859.e15; quiz 873-4. PubMed ID: 25437978
[TBL] [Abstract][Full Text] [Related]
9. Trends in the prescribing pattern of spironolactone for acne and hidradenitis suppurativa in adolescents.
Horissian M; Maczuga S; Barbieri JS; Zaenglein AL
J Am Acad Dermatol; 2022 Sep; 87(3):684-686. PubMed ID: 34896127
[No Abstract] [Full Text] [Related]
10. Spironolactone in dermatology.
Cunliffe WJ
J Am Acad Dermatol; 1992 Jan; 26(1):137-8. PubMed ID: 1531055
[No Abstract] [Full Text] [Related]
11. Androgens in women: Hormone-modulating therapies for skin disease.
Azarchi S; Bienenfeld A; Lo Sicco K; Marchbein S; Shapiro J; Nagler AR
J Am Acad Dermatol; 2019 Jun; 80(6):1509-1521. PubMed ID: 30312645
[TBL] [Abstract][Full Text] [Related]
12. Nodulocystic acne and hidradenitis suppurativa treated with acitretin: a case report.
Scheman AJ
Cutis; 2002 Apr; 69(4):287-8. PubMed ID: 12080949
[TBL] [Abstract][Full Text] [Related]
13. Isotretinoin-associated acne fulminans: A multicentre, retrospective study of the European Academy of Dermatology and Venereology Task Force on Acne, Rosacea and Hidradenitis Suppurativa.
Dessinioti C; Dréno B; Bettoli V; Vural S; Brzezinski P; Nassif A; Svensson Å; Zouboulis CC
J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):197-204. PubMed ID: 37643921
[TBL] [Abstract][Full Text] [Related]
14. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
Brown J; Farquhar C; Lee O; Toomath R; Jepson RG
Cochrane Database Syst Rev; 2009 Apr; (2):CD000194. PubMed ID: 19370553
[TBL] [Abstract][Full Text] [Related]
15. Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism.
Karrer-Voegeli S; Rey F; Reymond MJ; Meuwly JY; Gaillard RC; Gomez F
Medicine (Baltimore); 2009 Jan; 88(1):32-45. PubMed ID: 19352298
[TBL] [Abstract][Full Text] [Related]
16. Tolerance of spironolactone.
Hughes BR; Cunliffe WJ
Br J Dermatol; 1988 May; 118(5):687-91. PubMed ID: 2969259
[TBL] [Abstract][Full Text] [Related]
17. Spironolactone therapy in hirsutism and acne.
Callan AW
Australas J Dermatol; 1988; 29(3):135-9. PubMed ID: 2978784
[No Abstract] [Full Text] [Related]
18. [CME Dermatology 23: Hidradenitis suppurativa].
Dahmen RA; Lautenschlager S
Praxis (Bern 1994); 2021; 110(7):363-372. PubMed ID: 34019444
[TBL] [Abstract][Full Text] [Related]
19. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
Farquhar C; Lee O; Toomath R; Jepson R
Cochrane Database Syst Rev; 2003; (4):CD000194. PubMed ID: 14583916
[TBL] [Abstract][Full Text] [Related]
20. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
Farquhar C; Lee O; Toomath R; Jepson R
Cochrane Database Syst Rev; 2001; (4):CD000194. PubMed ID: 11687072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
